Expertise in
7
conditions

Ganessan Kichenadasse

Bedford Park, 
Adelaide, SA, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Bedford Park, 
Adelaide, SA, AU 

Overview

Ganessan Kichenadasse practices practicing medicine in Adelaide, Australia.

Kichenadasse is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Prostate Cancer, Febrile Neutropenia, Lung Cancer, Ovarian Cancer, and Prostatectomy.

They are actively involved in clinical research, co-authoring 153 peer reviewed articles and participating in 8 clinical trials.

Locations

Bedford Park, Adelaide, SA, Australia
Other Locations
Flinders Drive, Bedford Park, Adelaide, SA 5042, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Enrollment Status: Recruiting
Publish Date: September 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Non-Steroidal Anti Androgen, Luteinizing Hormone Releasing Hormone Analog or Surgical Castration
Study Phase: Phase 3
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Named Patient Use Program to Provide Abemaciclib for the Treatment of Metastatic Breast Cancer
Enrollment Status: Approved_for_marketing
Publish Date: December 16, 2024
Intervention Type: Drug
Phase I Study of Intra-peritoneal Cantrixil in Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
Phase I Study of Intra-peritoneal Cantrixil in Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase I, First-in-Human, Open-Label, Dose Escalation Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumors
A Phase I, First-in-Human, Open-Label, Dose Escalation Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumors
Enrollment Status: Terminated
Publish Date: October 10, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer
Enrollment Status: Completed
Publish Date: August 19, 2022
Intervention Type: Drug
Study Drug: Prexasertib
Study Phase: Phase 2
A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602).
A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602).
Enrollment Status: Unknown
Publish Date: February 16, 2022
Intervention Type: Drug
Study Drugs: Nivolumab, Ipilimumab
Study Phase: Phase 2
A Phase I Study Evaluating Safety, Tolerability, and Pharmacokinetics of SCB-313, a Fully-Human TRAIL-Trimer Fusion Protein, for the Treatment of Peritoneal Malignancies
A Phase I Study Evaluating Safety, Tolerability, and Pharmacokinetics of SCB-313, a Fully-Human TRAIL-Trimer Fusion Protein, for the Treatment of Peritoneal Malignancies
Enrollment Status: Completed
Publish Date: October 19, 2021
Intervention Type: Drug
Study Drug: SCB-313 TRAIL-Trimer Fusion Protein
Study Phase: Phase 1
View 7 Less Clinical Trials

153 Total Publications

Patient-reported outcomes in Australian oncology: from emerging practice to system-wide care.
Patient-reported outcomes in Australian oncology: from emerging practice to system-wide care.
Journal: Internal medicine journal
Published: July 07, 2026

Frequently Asked Questions about Ganessan Kichenadasse

Is Ganessan Kichenadasse a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ganessan Kichenadasse is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ganessan Kichenadasse participate in research or clinical trials?

Yes. Ganessan Kichenadasse has published 153 articles and abstracts on conditions like Prostate Cancer. You can view a list of Ganessan Kichenadasse's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kichenadasse's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 26 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile